MUNIT, with Jetpharma and Microchem, invite you to join us at RDD 2022 – Respiratory Drug Delivery 2022.
The event will be in-person at the Omni Orlando ChampionsGate in Orlando, Florida, from May 1-5, 2022.
As a result of the Covid-19 pandemic, drug delivery to the nose and lungs has never been in a brighter spotlight, and never has it been more important for companies and researchers to share that attention after two years of virtual conferences. RDD 2022 will combine best-practices gleaned from life online with the irreplaceable value of face-to-face interactions to bring the respiratory world together. Here’s how:
- Knowledge Spaces will organize scientific content by theme so that related expert presentations, posters and company exhibits are together online, and easy to associate in the physical space in Florida.
- All delegates will be able to view presentations, posters and exhibits but on-demand access to some content may not be available until several days after the live event. Electronic access to published conference articles will be available from April 25, 2022 to June 30, 2023.
- RDD 2022 will afford conference sponsors maximum visibility and companies will benefit from an expanded virtual presence when they commit to running an in-person exhibit table.
Respiratory Drug Delivery and the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) will again collaborate to develop a jointly organized session on Thursday May 5 that will address Regulatory, Science and Technology Innovations Enabling Novel and Improved OINDP Design, Development and Manufacturing. The podium presentations will be supplemented with subsequent in-depth roundtables (delivered online after RDD 2022).
In case you are not ready, willing, or able to travel to the United States yet, we have made provision for online participation in the many events that have made RDD the must-attend, quality international conference concerning all aspects of pulmonary and nasal drug delivery. In-depth presentations and discussion of pioneering science in tandem with expanded opportunities for networking will appeal to scientists, regulators, clinicians, solutions providers, and business professionals active in this exciting field.
Please, find out more here: https://www.rddonline.com/rdd/rdd.php?id=21&sid=1